Search details
1.
Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.
Brain
; 146(4): 1697-1713, 2023 04 19.
Article
in English
| MEDLINE | ID: mdl-36148553
2.
Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas.
Int J Mol Sci
; 22(2)2021 Jan 08.
Article
in English
| MEDLINE | ID: mdl-33429944
3.
A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated Tumours.
Int J Mol Sci
; 21(4)2020 Feb 13.
Article
in English
| MEDLINE | ID: mdl-32070062
4.
A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomas.
Acta Neuropathol Commun
; 11(1): 198, 2023 Dec 15.
Article
in English
| MEDLINE | ID: mdl-38102708
5.
The role of insulin-like growth factors signaling in merlin-deficient human schwannomas.
Glia
; 60(11): 1721-33, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-22821509
6.
Human Endogenous Retrovirus Type K Promotes Proliferation and Confers Sensitivity to Antiretroviral Drugs in Merlin-Negative Schwannoma and Meningioma.
Cancer Res
; 82(2): 235-247, 2022 01 15.
Article
in English
| MEDLINE | ID: mdl-34853069
7.
GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma.
EBioMedicine
; 59: 102941, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32810829
8.
Constitutive activation of the EGFR-STAT1 axis increases proliferation of meningioma tumor cells.
Neurooncol Adv
; 2(1): vdaa008, 2020.
Article
in English
| MEDLINE | ID: mdl-32642677
9.
The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma.
Cancers (Basel)
; 12(7)2020 Jun 30.
Article
in English
| MEDLINE | ID: mdl-32629964
10.
HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis.
J Clin Invest
; 130(7): 3848-3864, 2020 07 01.
Article
in English
| MEDLINE | ID: mdl-32315290
11.
NAADP activates a Ca2+ current that is dependent on F-actin cytoskeleton.
FASEB J
; 17(13): 1907-9, 2003 Oct.
Article
in English
| MEDLINE | ID: mdl-12923070
12.
Merlin-deficient human tumors show loss of contact inhibition and activation of Wnt/ß-catenin signaling linked to the PDGFR/Src and Rac/PAK pathways.
Neoplasia
; 13(12): 1101-12, 2011 Dec.
Article
in English
| MEDLINE | ID: mdl-22247700
13.
A concise entry into nonsymmetrical alkyl polyamines.
Org Lett
; 10(19): 4199-202, 2008 Oct 02.
Article
in English
| MEDLINE | ID: mdl-18763798
14.
Characterization of NAD uptake in mammalian cells.
J Biol Chem
; 283(10): 6367-74, 2008 Mar 07.
Article
in English
| MEDLINE | ID: mdl-18180302
15.
Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvage.
ChemMedChem
; 3(5): 771-9, 2008 May.
Article
in English
| MEDLINE | ID: mdl-18247435
16.
Modulation of calcium signalling by the actin-binding protein cofilin.
Biochem Biophys Res Commun
; 348(1): 109-14, 2006 Sep 15.
Article
in English
| MEDLINE | ID: mdl-16875665
17.
The M-phase-promoting factor modulates the sensitivity of the Ca2+ stores to inositol 1,4,5-trisphosphate via the actin cytoskeleton.
J Biol Chem
; 278(43): 42505-14, 2003 Oct 24.
Article
in English
| MEDLINE | ID: mdl-12867432
Results
1 -
17
de 17
1
Next >
>>